Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis

Respiratory Medicine

Volumn 109, Issue 2, 2015, Pages 208-217

  Papi, Alberto ^a   Price, David ^b   Sastre, Joaquin ^c   Kaiser, Kirsten ^d   Lomax, Mark ^e   McIver, Tammy ^e   Dissanayake, Sanjeeva ^e  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^d Skyepharma ^*  (Switzerland)

^e Mundipharma Research Limited   (United Kingdom)

Author keywords

Asthma; Combination therapy; Efficacy; Fluticasone propionate; Formoterol fumarate

Indexed keywords

CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE PLUS FORMOTEROL FUMARATE; SALBUTAMOL; BRONCHODILATING AGENT; FORMOTEROL FUMARATE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BACKACHE; BRONCHITIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; DISEASE CONTROL; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INCIDENCE; INFLUENZA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MONOTHERAPY; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RHINOPHARYNGITIS; SINUSITIS; SLEEP DISORDER; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; AGED; CHILD; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; FLUTICASONE; FORCED EXPIRATORY VOLUME; FORMOTEROL FUMARATE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923095254     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.10.019     Document Type: Article

References (39)

1. GINA. Global strategy for asthma management and prevention, http://www.ginasthma.org/local/uploads/files/GINA-Report-2012Feb13.pdf; [Date last updated: December 2012. Date last accessed: May 3 2013].
2. M.R. Partridge, T. van der Molen, S.E. Myrseth, and W.W. Busse Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study BMC Pulm Med 6 2006 13
3. C. Marceau, C. Lemière, D. Berbiche, S. Perreault, and L. Blais Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma J Allergy Clin Immunol 118 3 2006 574 581
4. K.R. Murphy, and B.G. Bender Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence J Asthma Allergy 2 2009 63 72
5. S. Rohatagi, S. Appajosyula, H. Derendorf, S. Szefler, R. Nave, K. Zech, and D. Banerji Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective J Clin Pharmacol 44 1 2004 37 47
6. M.J. Politiek, M. Boorsma, and R. Aalbers Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction Eur Respir J 13 5 1999 988 992
7. J.A. van Noord, J.J. Smeets, and F.P. Maesen A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction Respir Med 92 12 1998 1346 1351
8. A.B. Hauber, A.F. Mohamed, F.R. Johnson, D. Meddis, S. Wagner, and L. O'Dowd Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications Allergy Asthma Proc 30 2 2009 139 147
9. B.G. Bender, A. Long, B. Parasuraman, and Z.V. Tran Factors influencing patient decisions about the use of asthma controller medication Ann Allergy Asthma Immunol 98 4 2007 322 328
10. N.K. Leidy, B. Gutierrez, K. Lampl, T. Uryniak, and C.D. O'Brien Can patients with asthma feel inhaler therapy working right away? Two clinical trials testing the effect of timing of assessment on patient perception J Asthma 46 10 2009 1006 1012
11. B. Johal, M. Howald, M. Fischer, J. Marshall, and G. Venthoye Fine particle profile of fluticasone propionate/formoterol fumarate versus other combination products: the DIFFUSE study Comb Prod Ther 3 1-2 2013 39 51
12. B. Johal, S. Murphy, and J. Marshall Plume characteristics of fluticasone propionate/formoterol pMDI compared with fluticasone propionate/salmeterol pMDI Eur Respir J 42 Suppl. 57 2013 P4132
13. A. Bodzenta-Lukaszyk, R. Buhl, B. Balint, M. Lomax, K. Spooner, and S. Dissanayake Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety J Asthma 49 10 2012 1060 1070
14. R. Aalbers, G. Brusselle, T. McIver, B. Grothe, and A. Bodzenta-Lukaszyk Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study Adv Ther 29 11 2012 958 969
15. A. Bodzenta-Lukaszyk, A. Dymek, K. McAulay, and H. Mansikka Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study BMC Pulm Med 11 2011 28
16. A. Bodzenta-Lukaszyk, G. Pulka, A. Dymek, D. Bumbacea, T. McIver, B. Schwab, and H. Mansikka Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler Respir Med 105 5 2011 674 682
17. J. Corren, L.E. Mansfield, T. Pertseva, V. Blahzko, and K. Kaiser Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma Respir Med 107 2 2013 180 195
18. R.A. Nathan, A. D'Urzo, V. Blazhko, and K. Kaiser Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial BMC Pulm Med 12 2012 67
19. A. Bodzenta-Lukaszyk, J. van Noord, W. Schröder-Babo, K. McAulay, and T. McIver Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial Curr Med Res Opin 29 5 2013 579 588
20. A.H. Mansur, and K. Kaiser Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma J Aerosol Med Pulm Drug Deliv 26 4 2013 190 199
21. T. Pertseva, S. Dissanayake, and K. Kaiser Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial Curr Med Res Opin 29 10 2013 1357 1369
22. D.S. Pearlman, C. LaForce, and K. Kaiser Fluticasone/formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma Clin Ther 35 7 2013 950 966
23. 1 spirometric endpoints as a measure of the anti-inflammatory and bronchodilatory effects of flucticasone/formoterol combination therapy Eur Respir J 42 Suppl. 57 2013 P4131
24. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, W.W. Busse, T.B. Casale, P. Chanez, P.L. Enright, P.G. Gibson, J.C. de Jongste, H.A. Kerstjens, S.C. Lazarus, M.L. Levy, P.M. O'Byrne, M.R. Partridge, I.D. Pavord, M.R. Sears, P.J. Sterk, S.W. Stoloff, S.D. Sullivan, S.J. Szefler, M.D. Thomas, and S.E. Wenzel An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 1 2009 59 99
25. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi, and J. Wanger Standardisation of spirometry Eur Respir J 26 2 2005 319 338
26. H.K. Reddel, C.R. Jenkins, G.B. Marks, S.I. Ware, W. Xuan, C.M. Salome, C.A. Badcock, and A.J. Woolcock Optimal asthma control, starting with high doses of inhaled budesonide Eur Respir J 16 2 2000 226 235
27. T. Haahtela, M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, K. Reinikainen, O. Selroos, A. Sovijarvi, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, and L.A. Laitinen Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma N Engl J Med 325 6 1991 388 392
28. ®) for the treatment of asthma Respir Med 97 6 2003 702 708
29. P.M. O'Byrne, H. Bisgaard, P.P. Godard, M. Pistolesi, M. Palmqvist, Y. Zhu, T. Ekström, and E.D. Bateman Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma Am J Respir Crit Care Med 171 2 2005 129 136
30. E.J. Sims, D. Price, J. Haughney, D. Ryan, and M. Thomas Current control and future risk in asthma management Allergy Asthma Immunol Res 3 4 2011 217 225
31. P.M. O'Byrne, P.J. Barnes, R. Rodriguez-Roisin, E. Runnerstrom, T. Sandstrom, K. Svensson, and A. Tattersfield Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial Am J Respir Crit Care Med 164 8 Pt 1 2001 1392 1397
32. D. Price, D. Dutchman, A. Mawson, B. Bodalia, S. Duggan, and P. Todd Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose Thorax 57 9 2002 791 798
33. F.M. Ducharme, M. Ni Chroinin, I. Greenstone, and T.J. Lasserson Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children Cochrane Database Syst Rev 5 2010 CD005535
34. A. Papi A, A.H. Mansur, S. Dissanayake, T. Pertseva, T. McIver, and K. Kaiser Long-term fluticasone propionate/formoterol fumarate combination therapy is associated with a low incidence of severe asthma exacerbations Respirology 18 Suppl. S4 2013 112 (PS 109)
35. R.A. Pauwels, C.G. Löfdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, P.J. Barnes, and A. Ullman Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 20 1997 1405 1411
36. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, R.A. Pauwels, and S.E. Pedersen Can-guideline-defined asthma control be achieved? The Gaining Optimum Asthma ControL study Am J Respir Crit Care Med 170 8 2004 836 844
37. S. Suissa, V. Patenaude, F. Lapi, and P. Ernst Inhaled corticosteroids in COPD and the risk of serious pneumonia Thorax 68 11 2013 1029 1036
38. C. Janson, K. Larsson, K.H. Lisspers, B. Ställberg, G. Stratelis, H. Goike, L. Jörgensen, and G. Johansson Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS) BMJ 346 2013 f3306
39. P.M. O'Byrne, S. Pedersen, L.G. Carlsson, F. Radner, A. Thorén, S. Peterson, P. Ernst, and S. Suissa Risks of pneumonia in patients with asthma taking inhaled corticosteroids Am J Respir Crit Care Med 183 5 2011 589 595